Institut Gustave Roussy-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Institut Gustave Roussy - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014039
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Institut Gustave Roussy (IGR) is a cancer research institute that offers healthcare services to patients suffering from cancer and conducts research to identify new therapies. The institute provides treatment for the diseases that include endocrine tumours, childhood cancer, gynecological cancers, brain tumours, gastrointestinal tumours, skin cancers, lung cancers, prostate cancers, bladder cancer, kidney cancer, oncogenetics, haematological cancers, sarcomas and complex tumours, and others. The institute also partners with Karolinska Institutet of Stockholm, Sweden; Uruguayan Ministry of Public Health; National Cancer Center of Tokyo, Japan; MD Anderson Cancer Center of Houston, the US; and others. IGR is headquartered in Villejuif, France.

Institut Gustave Roussy – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Institut Gustave Roussy, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Institut Gustave Roussy, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Institut Gustave Roussy, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Institut Gustave Roussy, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Institut Gustave Roussy, Medical Devices Deals, 2011 to YTD 2017 9
Institut Gustave Roussy, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Institut Gustave Roussy, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
RXi Pharma and Gustave Roussy Enter into Research Agreement 11
Merus Enters into Co-Development Agreement with Institut Gustave Roussy 12
Enterome Bioscience Enters into Co-Development Agreement with Gustave Roussy 13
New Oncology Enters into Research Agreement with Gustave Roussy Cancer Campus 14
Gustave Roussy Enters into Research Agreement with AstraZeneca 15
Ipsen Enters Into Co-Development Agreement With Institut Gustave Roussy 16
Licensing Agreements 17
Therapeutic Solutions International Enters into Licensing Agreement with Gustave Roussy 17
Institut Gustave Roussy – Key Competitors 18
Institut Gustave Roussy – Key Employees 19
Institut Gustave Roussy – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Institut Gustave Roussy, Pharmaceuticals & Healthcare, Key Facts 2
Institut Gustave Roussy, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Institut Gustave Roussy, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Institut Gustave Roussy, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Institut Gustave Roussy, Deals By Therapy Area, 2011 to YTD 2017 8
Institut Gustave Roussy, Medical Devices Deals, 2011 to YTD 2017 9
Institut Gustave Roussy, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
RXi Pharma and Gustave Roussy Enter into Research Agreement 11
Merus Enters into Co-Development Agreement with Institut Gustave Roussy 12
Enterome Bioscience Enters into Co-Development Agreement with Gustave Roussy 13
New Oncology Enters into Research Agreement with Gustave Roussy Cancer Campus 14
Gustave Roussy Enters into Research Agreement with AstraZeneca 15
Ipsen Enters Into Co-Development Agreement With Institut Gustave Roussy 16
Therapeutic Solutions International Enters into Licensing Agreement with Gustave Roussy 17
Institut Gustave Roussy, Key Competitors 18
Institut Gustave Roussy, Key Employees 19
Institut Gustave Roussy, Subsidiaries 20

★海外企業調査レポート[Institut Gustave Roussy-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • QBE Insurance Group Limited:戦略・SWOT・企業財務分析
    QBE Insurance Group Limited - Strategy, SWOT and Corporate Finance Report Summary QBE Insurance Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cowen Inc:企業の戦略・SWOT・財務情報
    Cowen Inc - Strategy, SWOT and Corporate Finance Report Summary Cowen Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Emirates National Oil Co Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Emirates National Oil Co Ltd (ENOC) is an oil and gas company that offers downstream and upstream activities. The company’s products include liquid petroleum gas, aviation fuel, lubricants, chemicals, and LPG containers. It offers services such as trading, supplying, processing, marketing, t …
  • Halozyme Therapeutics Inc (HALO):企業の財務・戦略的SWOT分析
    Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • GKN Aerospace Services Ltd:企業の戦略的SWOT分析
    GKN Aerospace Services Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • SM Energy Co (SM):企業の財務・戦略的SWOT分析
    SM Energy Co (SM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Beijing Shouhang IHW Resources Saving Technology Co Ltd (002665):電力:M&Aディール及び事業提携情報
    Summary Beijing Shouhang IHW Resources Saving Technology Co Ltd (Shouhang IHW Resources) is an electrical equipment company that offers heat generation systems. The company designs, manufactures and distributes CSP power generating system, thermal power plant air cooling system, waste heat power gen …
  • VIA Technologies, Inc (2388):企業の財務・戦略的SWOT分析
    VIA Technologies, Inc (2388) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • George Weston Limited:企業の戦略・SWOT・財務情報
    George Weston Limited - Strategy, SWOT and Corporate Finance Report Summary George Weston Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Rohol-Aufsuchungs Aktiengesellschaft:石油・ガス:M&Aディール及び事業提携情報
    Summary Rohol-Aufsuchungs Aktiengesellschaft (RAG) is an oil and gas company. The company operates in oil and gas exploration, production and trading; and gas storage. It produces crude oil and natural gas. RAG offers services such as renewable energy projects development and crude oil stockpiling a …
  • Zhuhai Holdings Investment Group Co Ltd
    Zhuhai Holdings Investment Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zhuhai Holdings Investment Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • AMC Networks Inc.:企業の戦略・SWOT・財務情報
    AMC Networks Inc. - Strategy, SWOT and Corporate Finance Report Summary AMC Networks Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ora Gold Ltd (THX):企業の財務・戦略的SWOT分析
    Summary Ora Gold Ltd (Ora Gold) is a mining and mineral exploration company. The company acquires, explores and develops lead, zinc, silver, nickel, graphite, copper, gold and uranium prospects in Western Australia and the Northern Territory. Its projects include Red Bore Copper-Gold Project, Garden …
  • Medpace Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Medpace Inc (Medpace), a subsidiary of Medpace Holdings Inc is a contract research organization that develops research based drug and medical device. The organization provides services such as medical affairs, regulatory affairs and medical writing, clinical monitoring, clinical trial manage …
  • ASOS Plc:企業の戦略・SWOT・財務情報
    ASOS Plc - Strategy, SWOT and Corporate Finance Report Summary ASOS Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Fujisoft Inc (9749):企業の財務・戦略的SWOT分析
    Fujisoft Inc (9749) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Mothercare plc (MTC):企業の財務・戦略的SWOT分析
    Mothercare plc (MTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Baker IDI Heart and Diabetes Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Baker IDI Heart and Diabetes Institute (Baker Institute) is a medical research organization that offers diagnosis, prevention, treatment of diabetics and cardiovascular disease. The organization offers clinical services such as diabetes services, weight assessment and management clinic healt …
  • Plantronics, Inc. (PLT):企業の財務・戦略的SWOT分析
    Plantronics, Inc. (PLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • MicroPort Scientific Corp (853):企業の財務・戦略的SWOT分析
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company which develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, e …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆